N-acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats

Peritoneal Dialysis International

Volumn 18, Issue 2, 1998, Pages 217-224

  Wu, George ^a   Wieczorowska Tobis, Katarzyna ^b   Polubinska, Alicja ^b   Korybalska, Katarzyna ^b   Filas, Violetta ^b   Tam, Paul ^b   French, Ian ^b   Breborowicz, Andrzej ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Morphology; N acetylglucosamine; Peritoneum; Permeability

Indexed keywords

ALCIAN BLUE; CREATININE; DIALYSIS FLUID; DIANEAL; GLUCOSE; N ACETYLGLUCOSAMINE; POLYANION; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIALYSATE; EFFLUENT; INTERSTITIUM; LEUKOCYTE COUNT; MALE; MORPHOLOGY; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PERMEABILITY; PRIORITY JOURNAL; RAT; STAINING; SUPPLEMENTATION;

EID: 0031945311     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089801800212     Document Type: Article

References (37)

1. Jörres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids. Int J Artif Organs 1992; 15:79-83.
2. Holmes CJ. Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13:88-94.
3. Di Paolo N, Sacchi G, De Mia M. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44:204-11.
4. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495-506.
5. Coles GA. Biocompatibility of various osmotic solutes. Perit Dial Int 1995; 15(7):S71-5.
6. Mistry CD, Gokal R. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S104-8.
7. Topley N, Kaur D, Petersen MM, Jörres A, Passlick-Deetjen J, Coles GA, et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49:1447-56.
8. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39:343-8.
9. Bos HJ, Struijk DG, Tuk CW, De Veld JC, Helehorst TJM, Hoefsmit ECM, et al. Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence. Nephron 1991; 59:508-9.
10. Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation. Kidney Int 1996; 49:506-11.
11. Gotloib L, Shostack A, Bar Sella P, Cohen R. Continuous mesothelial injury and regeneration during long term peritoneal dialysis. Perit Dial Bull 1987; 7:148-55.
12. Yung S, Cole GA, Williams JD, Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46:527-33.
13. Wieczorowska K, Breborowicz A, Martis L, Oreopoulos DG. Protective effect of hyaluronic acid against peritoneal injury. Perit Dial Int 1995; 15:81-3.
14. Breborowicz A, Wieczorowska-Tobis K, Kuzlan M, Kupsz J, Korybalska K, Polubinska A, et al. N-Acetyl-glucosamine: A new osmotic solute in peritoneal dialysis solutions. Perit Dial Int 1997; 17(Suppl 2):S80-3.
15. Lowry OH, Rosenbrough NJ, Rarr AL. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
16. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev 1978; 58:255-319.
17. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in early events during the inflammatory response and wound healing. J Theor Biol 1986; 119:219-26.
18. Breborowicz A, Wieczorowska K, Martis L, Oreopoulos DG. Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats. Nephron 1994; 67:346-50.
19. Bazzato G, Fracasso A, Gambaro G, Baggio B. Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis. Lancet 1995; 346:740-1.
20. Roden L. Effect of hexosamines on the synthesis of chondroitin sulphuric acid in vitro. Arkiv for Kemi 1956; 10:345-52.
21. 3H]glucosamine incorporation into hyaluronic acid by fibroblasts is modulated by culture conditions. Matrix 1990; 10:75-83.
22. Whiteman P. The quantitative measurement of alcianblue glycosaminoglycan complexes. Biochem J 1973; 131:343-50.
23. Ogston AG, Sherman TF. Effects of hyaluronic acid upon diffusion of solutes and flow of solvent. J Physiol 1961; 156:67-74.
24. Breborowicz A, Radkowski M, Knapowski J, Oreopoulos DG. Effects of chondroitin sulphate on fluid and solute transport during peritoneal dialysis in rats. Perit Dial Int 1991; 11:351-4.
25. Gambaro G, Cavazzana AO, Luzi P, Piccoli A, Borsati A, Crepaldi G, et al. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 1992; 42:285-91.
26. Rao NV, Kennedy TP, Rao G, Ky N, Hoidal JR. Sulfated polysaccharides prevent human leukocyte elastase-induced acute lung injury and emphysema in hamsters. Am Rev Respir Dis 1990; 142:407-12.
27. Akatsuka M, Yamamoto Y, Tobetto K, Yasui T, Ando T. Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leukocytes. J Pharm Pharmacol 1993; 45:110-14.
28. Fibbi G, Vannucchi S, Cavallini P, Del Rosso M, Pasquali F, Cappelletti R, et al. Involvement of chondroitin sulphate in preventing adhesive cellular interactions. Biochim Biophys Acta 1983; 762:512-18.
29. Abatangelo G, Martelli M, Vecchia P. Healing of hyaluronic acid-enriched wounds: histological observations. J Surg Res 1983; 35:410-16.
30. King SR, Hickerson WL, Proctor KG. Beneficial actions of exogenous hyaluronic acid on wound healing. Surgery 1991; 109:76-84.
31. Gries E, Paar D, Graben N, Bock KD. Intraperitoneal fibrin-formation and its inhibition in CAPD. Clin Nephrol 1986; 26:209-12.
32. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
33. Hakansson L, Venge P. The molecular basis of the hyaluronic acid-mediated stimulation of granulocyte function. J Immunol 1987; 138:4347-52.
34. Gerdin B, Hallgren R. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 1997; 242:49-55.
35. Zakaria ER, Lofthouse J, Flessner MF. Fluid loss from the peritoneal cavity is dependent on dilution and washout of the interstitial matrix (Abstract). J Am Soc Nephrol 1997; 8:294A.
36. Kohn P, Winzler RJ, Hoffmann RC. Metabolism of D-glucosamine and N-acetyl-D-glucosamine in the intact rat. J Biol Chem 1962; 237:304-8.
37. Laurent UBG, Reed RK. Turnover of hyaluronan in the tissues. Adv Drug Del Rev 1991; 7:237-56.